Authors


Penny Asbell, MD, MBA, FACS, FARVO

Latest:

Cyclosporine drop for treating dry eye offers new advantages

Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation


Shivani Majmudar

Latest:

One shingle at a time: Starting a solo practice

Sometimes, the best job for you is the one you create.


Delu Song, MD, PhD, MTR

Latest:

IVIg, ICVM may help patients with small fiber neuropathy, neuropathic corneal pain

NCP should be considered for patients with discomfort, irritation, dryness, grittiness.




David A. Eichenbaum, MD

Latest:

Take-Home Points for the Treatment of AMD and DME

David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.


Daniel Rodriguez-Florido

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Roger A. Goldberg, MD, MBA

Latest:

Case 3: Treating nAMD in the Presence of Geographic Atrophy

Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.


Deborah Ristvedt, DO

Latest:

Adherence and tolerability are key in treatment of hypertension and glaucoma

Priorities can ensure optimal outcomes for patients diagnosed with diseases.


Marta Villalba González, MD

Latest:

Tools can detect corneal nerve damage early

Noncontact esthesiometry screens for all levels of neurotrophic keratitis.


William Tarver, MD

Latest:

Investigators research ocular health after space flight

Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.


Susan Watson, MD

Latest:

Next-generation MGD: Patients in their 20s, 30s offer new perspectives

Long-term screen users and contact lens wearers in group face challenges.


Julie Anush Kazaryan, BS

Latest:

Blog: MRI findings of undereye filler and filler migration

Hyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common complications, and optimal injection techniques. Imaging tools such as MRI can prove to be beneficial for patient assessment.



Carl Danzig, MD

Latest:

Case 3: Treating nAMD in the Presence of Geographic Atrophy

Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.


Robert T Ang, MD

Latest:

Two-year results of laser scleral microporation

Procedure can reduce scleral biomechanical stiffness and rejuvenate dynamic range of focus.


Leon W. Herndon, Jr, MD

Latest:

From waste to wonder: Transformational advances in scleral allograft technology

Unlocking the potential of donor scleral tissue: Innovations and future applications.


Sunil Mamtora, MD

Latest:

A portable solution for high-definition slit lamp imaging

TAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.


Peter Mortensen, MD

Latest:

Investigators research ocular health after space flight

Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.


David M. Brown, MD

Latest:

Future of Intravitreal Injection

Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.


David R. Lally, MD

Latest:

Safety of Advanced Therapies in Clinical Trials vs Real World Experience

Lisa J. Faia, MD asks the panel about their concerns regarding the safety of newer agents for the broad array of retinal vascular diseases, highlighting the similarities and differences between clinical trial outcomes and real-world results.


Omar R. Shakir, MD, MBA

Latest:

Office-based vitrectomy a viable alternative to hospital, surgery

The option is a definitive step forward in the field of vitreoretinal surgery


Oluwatosin U. Smith, MD

Latest:

EyeCon 2024: Program co-chair Oluwatosin U. Smith, MD, talks about her love for research and education

From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.


Radhika Rampat, MBBS, FRCOphth

Latest:

Standardizing terminology for clarity in refractive surgery

Language can drive understanding, trust, and better outcomes for patients


T.Y. Alvin Liu, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


R.V. Paul Chan, MD

Latest:

Partners collaborate on integration of AI-supported ROP telemedicine globally

Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.


Jibran Sharieff, MD

Latest:

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.


Mark Milner
Mark S. Milner, MD

Latest:

The benefits of cryopreserved amniotic membrane during COVID-19

CAM’s regenerative healing means long-term relief and fewer visits to clinic.


Anat Loewenstein, MD

Latest:

Listening to the heart: Lessons from cardiology in remote monitoring and AI

Physicians explore how other specialties adopted and integrated remote monitoring into plans.


Larry Hanover

Latest:

The untapped potential of cell and gene therapy as treatment option

Investigators continue to break new ground, giving hope to patients, physicians.

© 2024 MJH Life Sciences

All rights reserved.